As President & CEO of Seoul National University Bundang Hospital (SNUBH), Prof Junghan Song leads one of Korea’s most important healthcare institutions. His scope of responsibility includes oversight of the SNUBH lab, which currently uses mass spectrometry for routine clinical testing, including drug analysis, toxicology assessment, biochemical genetics testing, analysis of diverse metabolites, and some protein-related assays.

In this Q&A with Mr Kit Tang, General Manager of Roche Diagnostics Korea, Prof Song draws upon his deep experience in laboratory medicine to share insights on the power of clinical mass spectrometry and the key considerations around the use of this technology.